Study title: Safety and tolerability of Kiddi Pharmaton Fizz effervescent tablets, comparing the marketed formula with an improved one with a reduced mineral amount, and a comparator product: A double-blind, controlled, randomised, three arm cross-over study in children.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: MINERALS AND VITAMINS | |||||
ATC code: A11JB | |||||
Document link: | |||||
Document date: | |||||
Study number: U00-0170 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |